OGN earnings date and last-quarter result: last quarter miss, P/E 14.23. Updated 2026-07-23.
Organon & (OGN) Research Hub
Organon & (OGN) trades on NYSE, US in the Healthcare (Drug Manufacturers - General) sector. As of 2026-10-26, shares last closed at 13.74 USD (-0.07%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 14.23, market cap 3.55B. This hub links to the full technical, earnings and options research available for OGN.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - General) |
|---|---|
| Exchange | NYSE, US |
| Last close | 13.74 USD (-0.07%) |
| 52-week range | 13.39 USD – 13.83 USD |
| Trend regime | Range |
| 14-day RSI | 50 (Neutral) |
| Trailing P/E | 14.23 |
| Market cap | 3.55B |
| Dividend yield | 0.59% |
Available research for OGN
Covered Call on OGN: how it works, illustrative setup around the real 13.74 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on OGN: how it works, illustrative setup around the real 13.74 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on OGN: how it works, illustrative setup around the real 13.74 USD price, max profit/loss, breakeven and when to use it. Educational.
OGN technical analysis: range, last 13.74 USD, RSI 50, 52w range 13.39 USD–13.83 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is OGN in?
Organon & (OGN) is classified under Healthcare (Drug Manufacturers - General), listed on NYSE, US.
Is OGN in an uptrend or downtrend?
As of 2026-10-26, OGN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is OGN's trailing P/E ratio?
OGN's trailing P/E is 14.23, with a market cap of 3.55B. See the earnings research page for full valuation detail.